Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-10

Clinical Trial Update: A Safety Study of PTI-125 in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 safety study of PTI-125 in healthy volunteers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PTI-125 (simufilam)

Snippet

Sponsor: Pain Therapeutics | Conditions: Alzheimer Disease, Early Onset, Alzheimer Disease | Phase 1 | Status: COMPLETED | Results posted: 2021-05-10